Computational Design of a Trivalent Multi-Epitope mRNA Vaccine Candidate Against Western, Eastern, and Venezuelan Equine Encephalitis Viruses
Pharmaceutical Research · 2026-10 · 43 (10) · 3717-3735
DOI: 10.1007/s11095-026-04192-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, online erschienen am 24.09.2026. Verfasst von Rongliu Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hos…. Hauptthemen laut MEDLINE: Encephalitis Virus, Venezuelan Equine, Viral Vaccines, Encephalitis Virus, Western Equine, Encephalitis Virus, Eastern Equine. Die Arbeit nennt 82 Literaturangaben. Gefördert von: the Natural Science Foundation of Changsha, the Natural Science Foundation of Hunan Province of China, the national key clinical specialist construction programs of China.
Abstract (Originalsprache)
PURPOSE: Western equine encephalitis virus (WEEV), Eastern equine encephalitis virus (EEEV), and Venezuelan equine encephalitis virus (VEEV) are mosquito-borne neurotropic alphaviruses that can cause severe encephalitis in humans and equids, yet no licensed vaccines are currently available for routine human prevention. This study aimed to computationally design a trivalent multi-epitope mRNA vaccine targeting WEEV, EEEV, and VEEV. METHODS: Immunoinformatics and reverse vaccinology approaches were used to identify conserved cytotoxic T-lymphocyte, helper T-lymphocyte, and linear B-cell epitopes from the three viruses. Fifteen candidate constructs incorporating different immunomodulatory strategies were evaluated for predicted antigenicity, safety, stability, and solubility, and the construct with the most balanced overall profile was selected for further analysis. Secondary- and tertiary-structure prediction, molecular docking, molecular dynamics (MD) simulations, binding free-energy analysis, and immune simulation were subsequently performed. RESULTS: WEV showed a favorable overall physicochemical and immunological profile, supporting its further structural and immunological characterization. Molecular docking demonstrated favorable interactions between WEV and TLR2, TLR3, and TLR4, with the strongest predicted HADDOCK score observed for TLR4. In contrast, molecular dynamics simulations and MM-PBSA analysis indicated greater dynamic stability and a more favorable estimated binding free energy for the WEV-TLR2 complex. In silico immune simulation predicted enhanced IgM and IgG production, B- and T-cell responses, memory-cell formation, and increased IFN-γ and IL-2 levels. CONCLUSIONS: WEV represents a computationally designed trivalent multi-epitope mRNA vaccine candidate against WEEV, EEEV, and VEEV. The present study provides a sequence-defined framework for the rational development of multivalent vaccines, and further in vitro and in vivo studies are warranted to evaluate antigen expression, immunogenicity, protective efficacy, and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
- Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, Hunan, China.
- Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disease, Xiangya Hospital, Changsha, Hunan, China.
- Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. 22041…
- Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, Hunan, China. 2204150422@csu.edu.cn.
Förderung
- the Natural Science Foundation of Changsha
- the Natural Science Foundation of Hunan Province of China
- the national key clinical specialist construction programs of China
- the National Natural Science Foundation of China
- the Major Research Project for High-Level Talents of Healthcare in Hunan Province
- the China Postdoctoral Science Foundation
Zitieren
APA
Qin, R., Luo, Y., Zhou, Z., Xu, Y., Wu, X., Hou, Y., Chen, J., Zhu, F., & Pan, P. (2026). Computational Design of a Trivalent Multi-Epitope mRNA Vaccine Candidate Against Western, Eastern, and Venezuelan Equine Encephalitis Viruses. Pharmaceutical Research, 43(10), 3717-3735. https://doi.org/10.1007/s11095-026-04192-3
Vancouver
Qin R, Luo Y, Zhou Z, Xu Y, Wu X, Hou Y, et al. Computational Design of a Trivalent Multi-Epitope mRNA Vaccine Candidate Against Western, Eastern, and Venezuelan Equine Encephalitis Viruses. Pharmaceutical Research. 2026;43(10):3717-3735. doi:10.1007/s11095-026-04192-3
BibTeX
@article{Qin2026,
author = {Qin, Rongliu and Luo, Yuying and Zhou, Ziyou and Xu, Yizhong and Wu, Xu and Hou, Yanqun and Chen, Jie and Zhu, Fei and Pan, Pinhua},
title = {Computational Design of a Trivalent Multi-Epitope mRNA Vaccine Candidate Against Western, Eastern, and Venezuelan Equine Encephalitis Viruses},
journal = {Pharmaceutical Research},
year = {2026},
volume = {43},
number = {10},
pages = {3717--3735},
doi = {10.1007/s11095-026-04192-3}
}
EUVIMED